| ¿µ¹® | acetic acid | ÇÑ±Û | ¾Æ¼¼Æ®»ê, ÃÊ»ê |
|---|---|---|---|
| ¼³¸í | ºÐÀÚ½ÄÀº C2H4O2, ºÐÀÚ·® 60.05ÀÇ Àú±Þ Áö¹æ»êÀÌ´Ù. CH3COOHÀÇ ±¸Á¶½ÄÀ» °¡Áø ¹«»ö¾×ü·Î 16.7¡É¿¡¼ ³ì°í 118.0¡É¿¡¼ ²ú´Â´Ù. ½ÄÃÊÀÇ ½Å¸ÀÀ» ³»´Â °ÍÀ̰í, ³óÃàµÈ °ÍÀ» ºùÃÊ»êÀ̶ó ÇÑ´Ù. »ó¿Â¿¡¼´Â ¾×üÀÌ¸ç ¼ö¿ë¾×Àº ¾à»ê¼ºÀÌ´Ù. »ýü³»¿¡¼´Â ÀϹÝÀûÀ¸·Î ¾Æ¼¼Æ¿ CoA·Î Á¸ÀçÇÏ¸ç ¾Æ¼¼Æ¿±âÀÇ °ø±Þ¿øÀÌ µÇ´Â ¿Ü¿¡ Áö¹æ»êÀ̳ª ½ºÅ×·ÎÀÌµå µîÀÇ »ý¼ºÀç·á·Î Áß¿äÇÏ´Ù. ¾Æ¼¼Æ¿ CoA·ÎºÎÅÍ´Â ÄÉÅæÃ¼°¡ ÇÕ¼ºµÇ¸ç Á¶Á÷ÀÇ ¿¡³ÊÁö¿øÀÌ µÈ´Ù. |
||
| ¿µ¹® | acetylsalicylic acid | ÇÑ±Û | ¾Æ¼¼Æ¿»ì¸®½Ç»ê |
|---|---|---|---|
| ¼³¸í | »óǰ¸íÀÌ ¾Æ½ºÇǸ°(asprin)ÀÎ ¾à. ´ëÇ¥ÀûÀÎ ºñ½ºÅ×·ÎÀ̵å Ç׿°¾àÀÌ´Ù. Áï Ç׿°Áõ(anti-inflammatory), ÁøÅë(analgesis), ÇØ¿(anti-pyretic)ÀÇ È¿°ú°¡ ¸ðµÎ ¶Ù¾î³ªÁö¸¸ À§ÀåÀå¾Ö, °ú´ÙÈ£Èí, ¶óÀÌÁõÈıº(Reye syndrome) µîÀÇ ºÎÀÛ¿ëÀÌ ÀÖ´Ù. |
||
| ¿µ¹® | uric acid | ÇÑ±Û | ¿ä»ê |
|---|---|---|---|
| ¼³¸í | °áÁ¤¼ºÀÇ »ê. 2, 6, 8-trioxypurine. ÈÇнÄÀº C5H4N4O3·Î »ç¶÷°ú µ¿¹°ÀÇ ¿ÀÁÜ¿¡¼ ¾òÀ» ¼ö ÀÖ´Ù. ÇÙÀÇ ´ë»ç»ê¹°ÀÇ Çϳª. ¹°, ¾ËÄÝ, ¿¡Å׸£(ether)¿¡´Â °ÅÀÇ ³ìÁö ¾ÊÀ¸³ª ¾ËÄ®¸®¿°ÀÇ ¿ë¾×¿¡´Â ³ì´Â´Ù. À̰ÍÀÇ ³ªÆ®·ý¿° ÇüÅÂ(sodium urate)°¡ °á¼®ÀÇ ´ëºÎºÐÀ» Â÷ÁöÇÑ´Ù. ±Þ¼º¹éÇ÷º´ Ä¡·á Ãʱâ´Ü°è¿Í Åëdz(Gout)¿¡¼ Ç÷Áß¿ä»êÀÌ ±Þ°ÝÈ÷ ¿À¸¦ ¼ö ÀÖ´Ù. |
||
| ¿µ¹® | acid-fast bacillus | ÇÑ±Û | Ç׻긷´ë±Õ, Ç×»ê±Õ |
|---|---|---|---|
| ¼³¸í | ¾Æ´Ò¸° »ö¼Ò¿¡ ¿°»öµÇ±â Èûµå³ª ÀÏ´Ü ¿°»öµÇ¸é °»êÀ¸·Î ó¸®ÇÏ¿©µµ Å»»öµÇÁö ¾Æ´ÏÇÏ´Â ¼¼±ÕÀ» ÅëÆ²¾î À̸£´Â ¸». °áÇØ±Õ, ³ªº´±Õ µûÀ§°¡ ÀÖ´Ù. |
||
| ¿µ¹® | acid-fast staining | ÇÑ±Û | Ç׻꿰»ö |
|---|---|---|---|
| ¼³¸í | Ç׻꼺¼ºÁú(Á»Ã³·³ ¿°»öÀÌ µÇÁö ¾ÊÀ¸³ª Çѹø ¿°»öÀÌ µÇ¸é »ê¼º¿ë¾×¿¡ ÀÇÇØ¼ Å»»öÀÌ µÇÁö ¾Ê´Â ¼ºÁú)À» °¡Áø ±Õ(¿¹¸¦ µé¸é °áÇÙ±Õ µî)ÀÇ °ËÃâ¿¡ ÀÌ¿ëµÇ´Â ¿°»ö¹æ¹ý. ¹æ¹ý¿¡´Â Ziehl-Neelson¹ý°ú Kinyoun¹ý µîÀÌ ÀÖ´Ù. |
||
| CNBP | cellular nucleic acid binding protein |
|---|---|
| INA | infectious nucleic acid; inferior nasal artery; International Neurological Association |
| NAP | nasion, point A, pogonion [convexity or concavity of the facial profile]; nerve action potential; ne... |
| NBP | needle biopsy of prostate; neoplastic brachial plexopathy; nucleic acid binding protein |
| PA | panic attack; pantothenic acid; paralysis agitans; paranoia; passive aggressive; pathology; patient'... |
| clofibric acid | 4-chlorophenoxyisobutyric acid |
|---|---|
| CDCA | Cholic acid , chenodeoxycholic acid |
| cicloxilic acid | cis-2-Hydroxy-2-phenyl-cyclohexanecarboxilic acid |
| (1S,3R)-ACPD | 1S, 3R)-aminocyclopentane-1, 3-dicarboxylic acid |
| 1,3-DMU | 1,3 dimethyluric acid |
| RNA probes | RNA, usually prepared by transcription from cloned DNA, which complements a specific mRNA or DNA and is generally used for studies of virus genes, distribution of specific RNA in tissues and cells, integration of viral DNA into genomes, transcription, etc. Whereas DNA probes are preferred for use at a more macroscopic level for detection of the presence of DNA/RNA from specific species or subspecies, RNA probes are preferred for genetic studies. Conventional labels for the RNA probe include radioisotope labels 32p and 125i and the chemical label biotin. RNA probes may be further divided by category into plus-sense RNA probes, minus-sense RNA probes, and antisense RNA probes. (12 Dec 1998) |
|---|---|
| molecular probes | A group of atoms or molecules attached to other molecules or cellular structures and used in studying the properties of these molecules and structures. Radioactive DNA or RNA sequences are used in molecular genetics to detect the presence of a complementary sequence by molecular hybridization. (12 Dec 1998) |
| DNA probes | Species- or subspecies-specific DNA (including complementary DNA (DNA, complementary), conserved genes, whole chromosomes, or whole genomes) used in hybridization studies in order to identify microorganisms, to measure DNA-DNA homologies, to group subspecies, etc. The DNA probe hybridises with a specific mRNA, if present. Conventional techniques used for testing for the hybridization product include dot blot assays, southern blot assays, and DNA:RNA hybrid-specific antibody tests. Conventional labels for the DNA probe include the radioisotope labels 32p and 125i and the chemical label biotin. The use of DNA probes provides a specific, sensitive, rapid, and inexpensive replacement for cell culture techniques for diagnosing infections. (12 Dec 1998) |
| DNA probes, HLA | DNA probes specific for the human leukocyte antigen genes, which represent the major histocompatibility determinants in humans. The four known loci are designated as a, b, c, and d. Specific antigens are identified by a locus notation and number, e.g., HLA-a11. The inheritance of certain HLA alleles is associated with increased risk for certain diseases (e.g., insulin-dependent diabetes mellitus). (12 Dec 1998) |
| DNA probes, HPV | DNA probes specific for the identification of human papilloma virus. (12 Dec 1998) |
| oligonucleotide probes | Synthetic or natural oligonucleotides used in hybridization studies in order to identify and study specific nucleic acid fragments, e.g., DNA segments near or within a specific gene locus or gene. The probe hybridises with a specific mRNA, if present. Conventional techniques used for testing for the hybridization product include dot blot assays, southern blot assays, and DNA:RNA hybrid-specific antibody tests. Conventional labels for the probe include the radioisotope labels 32p and 125i and the chemical label biotin. (12 Dec 1998) |
| nucleic acids | Highly complex portions of nucleoproteins that yield a mixture of purines and pyrimidines, a ribose or deoxyribose component, and phosphoric acid on complete hydrolysis. The two general types are ribonucleic acid (RNA) and deoxyribonucleic acid (DNA). (12 Dec 1998) |
| nucleic acids, nucleotides, and nucleosides | Complex compounds of high molecular weight occurring in living cells. These are basically of two types, ribonucleic (RNA) and deoxyribonucleic (DNA) acids, both of which consist of nucleotides (nucleoside phosphates linked together by phosphate bridges). (12 Dec 1998) |
| Rambourg's chromic acid-phosphotungstic acid stain | <technique> A stain for glycoproteins, used with an electron microscope, with which ultrathin tissue sections reveal complex carbohydrates in the same locations as shown by Rambourg's periodic acid-chromic methenamine-silver stain. (05 Mar 2000) |
| a1-acid glycoprotein | <biology> Plasma protein of mammals and birds, 38% carbohydrate. In humans a single chain glycoprotein of 39 kD. Increased levels are associated with inflammation, pregnancy and various diseases. (18 Nov 1997) |
| abscisic acid | <biochemistry> A lipid hormone that inhibits cell growth in plants, it is associated with fruit drop, leaf death and seed dormancy. It is synthesised in the plastids from carotenoids. This hormone helps plants deal with water loss, and its effects can be reversed with gibberellins. (06 May 1997) |
| abscisic acid 8'-hydroxylase | <enzyme> Catalyses conversion of abscisic acid to 8'-hydroxyabscisic acid, which rearranges to phaseic acid Registry number: EC 1.14.99.- Synonym: aba 8'-hydroxylase (26 Jun 1999) |
| acetic acid | <chemical> The acid most commonly associated with vinegar, it is the most commercially important organic acid and is used to manufacture a wide range of chemical products, such as plastics and Acetobacter but, except for making vinegar, is usually made through synthetic processes. Derivatives of acetic acid which may be formed by substitution reactions. Mono- and di-substituted, as well as, halogenated compounds have been synthesised. Experimentally, alpha- and n2- substituted acetic acids have been examined for their anti-inflammatory activity and effect on the central nervous system respectively. Additionally, limited exposure data has been collected on dibromo and dichloroacetic acids to determine whether they pose health effects. Synonym: ethanoic acid. (26 Jun 1999) |
| acetoacetic acid | CH3COCH2COOH;one of the ketone bodies, formed in excess and appearing in the urine in starvation or diabetes. Synonym: diacetic acid. (05 Mar 2000) |
| acetohydroxamic acid | C2H5NO2; N-Hydroxyacetamide;an inhibitor of urease, used as adjunctive therapy in chronic urea-splitting urinary infections. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|